Latest return on equity
abrdn Life Sciences Investors Return on equity
abrdn Life Sciences Investors (HQL) return on equity with its verified observat…
Direct answer
abrdn Life Sciences Investors's return on equity is 41.42%.
The verified market snapshot reports 41.42%.
Bullstory displays the reported value and does not estimate missing data.
Market data checked September 3, 2026.
Get free abrdn Life Sciences Investors email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Return on equity
- 41.42%
Explore related company data
View abrdn Life Sciences Investors's market capitalizationView abrdn Life Sciences Investors's p/e ratioView abrdn Life Sciences Investors's price-to-book ratioView abrdn Life Sciences Investors's dividend yieldView abrdn Life Sciences Investors's 52-week price rangeView abrdn Life Sciences Investors's revenue growthView abrdn Life Sciences Investors's profit marginView all abrdn Life Sciences Investors key metricsReturn to abrdn Life Sciences Investors profile